PHAR · Healthcare · $707M
$9.99-0.20%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“루코네스트(RUCONEST) 매출이 전년 대비 10% 줄었지만, 직전 분기(Q1) 대비로는 24% 반등했어요.”
In the company's words · 2026 2분기 earnings call